Global Acinetobacter Infections Treatment Market Insights, Forecast to 2026
Table of Contents1 Study Coverage
1.1 Acinetobacter Infections Treatment Product Introduction
1.2 Market Segments
1.3 Key Acinetobacter Infections Treatment Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Acinetobacter Infections Treatment Market Size Growth Rate by Type
1.4.2 Sulbactam
1.4.3 Carbapenems
1.4.4 Aminoglycosides
1.4.5 Polymyxins
1.4.6 Tetracyclines
1.4.7 Others
1.5 Market by Application
1.5.1 Global Acinetobacter Infections Treatment Market Size Growth Rate by Application
1.5.2 ETX2514
1.5.3 Nacubactam RG6080
1.5.4 Arenicin
1.5.5 VXD-001
1.5.6 Small molecule antibiotic
1.5.7 AR-401 mAB
1.5.8 LCB01-0371 (PO)
1.5.9 GN-4474
1.5.10 Antibacterial Antibody
1.6 Coronavirus Disease 2019 (Covid-19): Acinetobacter Infections Treatment Industry Impact
1.6.1 How the Covid-19 is Affecting the Acinetobacter Infections Treatment Industry
1.6.1.1 Acinetobacter Infections Treatment Business Impact Assessment - Covid-19
1.6.1.2 Supply Chain Challenges
1.6.1.3 COVID-19's Impact On Crude Oil and Refined Products
1.6.2 Market Trends and Acinetobacter Infections Treatment Potential Opportunities in the COVID-19 Landscape
1.6.3 Measures / Proposal against Covid-19
1.6.3.1 Government Measures to Combat Covid-19 Impact
1.6.3.2 Proposal for Acinetobacter Infections Treatment Players to Combat Covid-19 Impact
1.7 Study Objectives
1.8 Years Considered
2 Executive Summary
2.1 Global Acinetobacter Infections Treatment Market Size Estimates and Forecasts
2.1.1 Global Acinetobacter Infections Treatment Revenue 2015-2026
2.1.2 Global Acinetobacter Infections Treatment Sales 2015-2026
2.2 Acinetobacter Infections Treatment Market Size by Region: 2020 Versus 2026
2.2.1 Global Acinetobacter Infections Treatment Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global Acinetobacter Infections Treatment Retrospective Market Scenario in Revenue by Region: 2015-2020
3 Global Acinetobacter Infections Treatment Competitor Landscape by Players
3.1 Acinetobacter Infections Treatment Sales by Manufacturers
3.1.1 Acinetobacter Infections Treatment Sales by Manufacturers (2015-2020)
3.1.2 Acinetobacter Infections Treatment Sales Market Share by Manufacturers (2015-2020)
3.2 Acinetobacter Infections Treatment Revenue by Manufacturers
3.2.1 Acinetobacter Infections Treatment Revenue by Manufacturers (2015-2020)
3.2.2 Acinetobacter Infections Treatment Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Acinetobacter Infections Treatment Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Acinetobacter Infections Treatment Revenue in 2019
3.2.5 Global Acinetobacter Infections Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Acinetobacter Infections Treatment Price by Manufacturers
3.4 Acinetobacter Infections Treatment Manufacturing Base Distribution, Product Types
3.4.1 Acinetobacter Infections Treatment Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Acinetobacter Infections Treatment Product Type
3.4.3 Date of International Manufacturers Enter into Acinetobacter Infections Treatment Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type (2015-2026)
4.1 Global Acinetobacter Infections Treatment Market Size by Type (2015-2020)
4.1.1 Global Acinetobacter Infections Treatment Sales by Type (2015-2020)
4.1.2 Global Acinetobacter Infections Treatment Revenue by Type (2015-2020)
4.1.3 Acinetobacter Infections Treatment Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Acinetobacter Infections Treatment Market Size Forecast by Type (2021-2026)
4.2.1 Global Acinetobacter Infections Treatment Sales Forecast by Type (2021-2026)
4.2.2 Global Acinetobacter Infections Treatment Revenue Forecast by Type (2021-2026)
4.2.3 Acinetobacter Infections Treatment Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Acinetobacter Infections Treatment Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Breakdown Data by Application (2015-2026)
5.1 Global Acinetobacter Infections Treatment Market Size by Application (2015-2020)
5.1.1 Global Acinetobacter Infections Treatment Sales by Application (2015-2020)
5.1.2 Global Acinetobacter Infections Treatment Revenue by Application (2015-2020)
5.1.3 Acinetobacter Infections Treatment Price by Application (2015-2020)
5.2 Acinetobacter Infections Treatment Market Size Forecast by Application (2021-2026)
5.2.1 Global Acinetobacter Infections Treatment Sales Forecast by Application (2021-2026)
5.2.2 Global Acinetobacter Infections Treatment Revenue Forecast by Application (2021-2026)
5.2.3 Global Acinetobacter Infections Treatment Price Forecast by Application (2021-2026)
6 North America
6.1 North America Acinetobacter Infections Treatment by Country
6.1.1 North America Acinetobacter Infections Treatment Sales by Country
6.1.2 North America Acinetobacter Infections Treatment Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America Acinetobacter Infections Treatment Market Facts & Figures by Type
6.3 North America Acinetobacter Infections Treatment Market Facts & Figures by Application
7 Europe
7.1 Europe Acinetobacter Infections Treatment by Country
7.1.1 Europe Acinetobacter Infections Treatment Sales by Country
7.1.2 Europe Acinetobacter Infections Treatment Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe Acinetobacter Infections Treatment Market Facts & Figures by Type
7.3 Europe Acinetobacter Infections Treatment Market Facts & Figures by Application
8 Asia Pacific
8.1 Asia Pacific Acinetobacter Infections Treatment by Region
8.1.1 Asia Pacific Acinetobacter Infections Treatment Sales by Region
8.1.2 Asia Pacific Acinetobacter Infections Treatment Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific Acinetobacter Infections Treatment Market Facts & Figures by Type
8.3 Asia Pacific Acinetobacter Infections Treatment Market Facts & Figures by Application
9 Latin America
9.1 Latin America Acinetobacter Infections Treatment by Country
9.1.1 Latin America Acinetobacter Infections Treatment Sales by Country
9.1.2 Latin America Acinetobacter Infections Treatment Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America Acinetobacter Infections Treatment Market Facts & Figures by Type
9.3 Central & South America Acinetobacter Infections Treatment Market Facts & Figures by Application
10 Middle East and Africa
10.1 Middle East and Africa Acinetobacter Infections Treatment by Country
10.1.1 Middle East and Africa Acinetobacter Infections Treatment Sales by Country
10.1.2 Middle East and Africa Acinetobacter Infections Treatment Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 UAE
10.2 Middle East and Africa Acinetobacter Infections Treatment Market Facts & Figures by Type
10.3 Middle East and Africa Acinetobacter Infections Treatment Market Facts & Figures by Application
11 Company Profiles
11.1 Entasis Therapeutics
11.1.1 Entasis Therapeutics Corporation Information
11.1.2 Entasis Therapeutics Description, Business Overview and Total Revenue
11.1.3 Entasis Therapeutics Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Entasis Therapeutics Acinetobacter Infections Treatment Products Offered
11.1.5 Entasis Therapeutics Recent Development
11.2 Roche
11.2.1 Roche Corporation Information
11.2.2 Roche Description, Business Overview and Total Revenue
11.2.3 Roche Sales, Revenue and Gross Margin (2015-2020)
11.2.4 Roche Acinetobacter Infections Treatment Products Offered
11.2.5 Roche Recent Development
11.3 Adenium Biotech
11.3.1 Adenium Biotech Corporation Information
11.3.2 Adenium Biotech Description, Business Overview and Total Revenue
11.3.3 Adenium Biotech Sales, Revenue and Gross Margin (2015-2020)
11.3.4 Adenium Biotech Acinetobacter Infections Treatment Products Offered
11.3.5 Adenium Biotech Recent Development
11.4 Vaxdyn
11.4.1 Vaxdyn Corporation Information
11.4.2 Vaxdyn Description, Business Overview and Total Revenue
11.4.3 Vaxdyn Sales, Revenue and Gross Margin (2015-2020)
11.4.4 Vaxdyn Acinetobacter Infections Treatment Products Offered
11.4.5 Vaxdyn Recent Development
11.5 Hsiri Therapeutics
11.5.1 Hsiri Therapeutics Corporation Information
11.5.2 Hsiri Therapeutics Description, Business Overview and Total Revenue
11.5.3 Hsiri Therapeutics Sales, Revenue and Gross Margin (2015-2020)
11.5.4 Hsiri Therapeutics Acinetobacter Infections Treatment Products Offered
11.5.5 Hsiri Therapeutics Recent Development
11.6 Aridis Pharmaceuticals
11.6.1 Aridis Pharmaceuticals Corporation Information
11.6.2 Aridis Pharmaceuticals Description, Business Overview and Total Revenue
11.6.3 Aridis Pharmaceuticals Sales, Revenue and Gross Margin (2015-2020)
11.6.4 Aridis Pharmaceuticals Acinetobacter Infections Treatment Products Offered
11.6.5 Aridis Pharmaceuticals Recent Development
11.7 LegoChem Biosciences
11.7.1 LegoChem Biosciences Corporation Information
11.7.2 LegoChem Biosciences Description, Business Overview and Total Revenue
11.7.3 LegoChem Biosciences Sales, Revenue and Gross Margin (2015-2020)
11.7.4 LegoChem Biosciences Acinetobacter Infections Treatment Products Offered
11.7.5 LegoChem Biosciences Recent Development
11.8 Atterx Biotherapeutics
11.8.1 Atterx Biotherapeutics Corporation Information
11.8.2 Atterx Biotherapeutics Description, Business Overview and Total Revenue
11.8.3 Atterx Biotherapeutics Sales, Revenue and Gross Margin (2015-2020)
11.8.4 Atterx Biotherapeutics Acinetobacter Infections Treatment Products Offered
11.8.5 Atterx Biotherapeutics Recent Development
11.9 Achaogen
11.9.1 Achaogen Corporation Information
11.9.2 Achaogen Description, Business Overview and Total Revenue
11.9.3 Achaogen Sales, Revenue and Gross Margin (2015-2020)
11.9.4 Achaogen Acinetobacter Infections Treatment Products Offered
11.9.5 Achaogen Recent Development
11.10 Peptilogics
11.10.1 Peptilogics Corporation Information
11.10.2 Peptilogics Description, Business Overview and Total Revenue
11.10.3 Peptilogics Sales, Revenue and Gross Margin (2015-2020)
11.10.4 Peptilogics Acinetobacter Infections Treatment Products Offered
11.10.5 Peptilogics Recent Development
11.1 Entasis Therapeutics
11.1.1 Entasis Therapeutics Corporation Information
11.1.2 Entasis Therapeutics Description, Business Overview and Total Revenue
11.1.3 Entasis Therapeutics Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Entasis Therapeutics Acinetobacter Infections Treatment Products Offered
11.1.5 Entasis Therapeutics Recent Development
11.12 Shionogi
11.12.1 Shionogi Corporation Information
11.12.2 Shionogi Description, Business Overview and Total Revenue
11.12.3 Shionogi Sales, Revenue and Gross Margin (2015-2020)
11.12.4 Shionogi Products Offered
11.12.5 Shionogi Recent Development
11.13 Techulon
11.13.1 Techulon Corporation Information
11.13.2 Techulon Description, Business Overview and Total Revenue
11.13.3 Techulon Sales, Revenue and Gross Margin (2015-2020)
11.13.4 Techulon Products Offered
11.13.5 Techulon Recent Development
11.14 Tetraphase Pharmaceuticals
11.14.1 Tetraphase Pharmaceuticals Corporation Information
11.14.2 Tetraphase Pharmaceuticals Description, Business Overview and Total Revenue
11.14.3 Tetraphase Pharmaceuticals Sales, Revenue and Gross Margin (2015-2020)
11.14.4 Tetraphase Pharmaceuticals Products Offered
11.14.5 Tetraphase Pharmaceuticals Recent Development
12 Future Forecast by Regions (Countries) (2021-2026)
12.1 Acinetobacter Infections Treatment Market Estimates and Projections by Region
12.1.1 Global Acinetobacter Infections Treatment Sales Forecast by Regions 2021-2026
12.1.2 Global Acinetobacter Infections Treatment Revenue Forecast by Regions 2021-2026
12.2 North America Acinetobacter Infections Treatment Market Size Forecast (2021-2026)
12.2.1 North America: Acinetobacter Infections Treatment Sales Forecast (2021-2026)
12.2.2 North America: Acinetobacter Infections Treatment Revenue Forecast (2021-2026)
12.2.3 North America: Acinetobacter Infections Treatment Market Size Forecast by Country (2021-2026)
12.3 Europe Acinetobacter Infections Treatment Market Size Forecast (2021-2026)
12.3.1 Europe: Acinetobacter Infections Treatment Sales Forecast (2021-2026)
12.3.2 Europe: Acinetobacter Infections Treatment Revenue Forecast (2021-2026)
12.3.3 Europe: Acinetobacter Infections Treatment Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific Acinetobacter Infections Treatment Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: Acinetobacter Infections Treatment Sales Forecast (2021-2026)
12.4.2 Asia Pacific: Acinetobacter Infections Treatment Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: Acinetobacter Infections Treatment Market Size Forecast by Region (2021-2026)
12.5 Latin America Acinetobacter Infections Treatment Market Size Forecast (2021-2026)
12.5.1 Latin America: Acinetobacter Infections Treatment Sales Forecast (2021-2026)
12.5.2 Latin America: Acinetobacter Infections Treatment Revenue Forecast (2021-2026)
12.5.3 Latin America: Acinetobacter Infections Treatment Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa Acinetobacter Infections Treatment Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: Acinetobacter Infections Treatment Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: Acinetobacter Infections Treatment Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: Acinetobacter Infections Treatment Market Size Forecast by Country (2021-2026)
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter's Five Forces Analysis
13.5 Primary Interviews with Key Acinetobacter Infections Treatment Players (Opinion Leaders)
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Acinetobacter Infections Treatment Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
List of TablesTable 1. Acinetobacter Infections Treatment Market Segments
Table 2. Ranking of Global Top Acinetobacter Infections Treatment Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Acinetobacter Infections Treatment Market Size Growth Rate by Type 2020-2026 (Cases) & (US$ Million)
Table 4. Major Manufacturers of Sulbactam
Table 5. Major Manufacturers of Carbapenems
Table 6. Major Manufacturers of Aminoglycosides
Table 7. Major Manufacturers of Polymyxins
Table 8. Major Manufacturers of Tetracyclines
Table 9. Major Manufacturers of Others
Table 10. COVID-19 Impact Global Market: (Four Acinetobacter Infections Treatment Market Size Forecast Scenarios)
Table 11. Opportunities and Trends for Acinetobacter Infections Treatment Players in the COVID-19 Landscape
Table 12. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 13. Key Regions/Countries Measures against Covid-19 Impact
Table 14. Proposal for Acinetobacter Infections Treatment Players to Combat Covid-19 Impact
Table 15. Global Acinetobacter Infections Treatment Market Size Growth Rate by Application 2020-2026 (Cases)
Table 16. Global Acinetobacter Infections Treatment Market Size by Region (Cases) & (US$ Million): 2020 VS 2026
Table 17. Global Acinetobacter Infections Treatment Sales by Regions 2015-2020 (Cases)
Table 18. Global Acinetobacter Infections Treatment Sales Market Share by Regions (2015-2020)
Table 19. Global Acinetobacter Infections Treatment Revenue by Regions 2015-2020 (US$ Million)
Table 20. Global Acinetobacter Infections Treatment Sales by Manufacturers (2015-2020) (Cases)
Table 21. Global Acinetobacter Infections Treatment Sales Share by Manufacturers (2015-2020)
Table 22. Global Acinetobacter Infections Treatment Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 23. Global Acinetobacter Infections Treatment by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Acinetobacter Infections Treatment as of 2019)
Table 24. Acinetobacter Infections Treatment Revenue by Manufacturers (2015-2020) (US$ Million)
Table 25. Acinetobacter Infections Treatment Revenue Share by Manufacturers (2015-2020)
Table 26. Key Manufacturers Acinetobacter Infections Treatment Price (2015-2020) (USD/Case)
Table 27. Acinetobacter Infections Treatment Manufacturers Manufacturing Base Distribution and Headquarters
Table 28. Manufacturers Acinetobacter Infections Treatment Product Type
Table 29. Date of International Manufacturers Enter into Acinetobacter Infections Treatment Market
Table 30. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 31. Global Acinetobacter Infections Treatment Sales by Type (2015-2020) (Cases)
Table 32. Global Acinetobacter Infections Treatment Sales Share by Type (2015-2020)
Table 33. Global Acinetobacter Infections Treatment Revenue by Type (2015-2020) (US$ Million)
Table 34. Global Acinetobacter Infections Treatment Revenue Share by Type (2015-2020)
Table 35. Acinetobacter Infections Treatment Average Selling Price (ASP) by Type 2015-2020 (USD/Case)
Table 36. Global Acinetobacter Infections Treatment Sales by Application (2015-2020) (Cases)
Table 37. Global Acinetobacter Infections Treatment Sales Share by Application (2015-2020)
Table 38. North America Acinetobacter Infections Treatment Sales by Country (2015-2020) (Cases)
Table 39. North America Acinetobacter Infections Treatment Sales Market Share by Country (2015-2020)
Table 40. North America Acinetobacter Infections Treatment Revenue by Country (2015-2020) (US$ Million)
Table 41. North America Acinetobacter Infections Treatment Revenue Market Share by Country (2015-2020)
Table 42. North America Acinetobacter Infections Treatment Sales by Type (2015-2020) (Cases)
Table 43. North America Acinetobacter Infections Treatment Sales Market Share by Type (2015-2020)
Table 44. North America Acinetobacter Infections Treatment Sales by Application (2015-2020) (Cases)
Table 45. North America Acinetobacter Infections Treatment Sales Market Share by Application (2015-2020)
Table 46. Europe Acinetobacter Infections Treatment Sales by Country (2015-2020) (Cases)
Table 47. Europe Acinetobacter Infections Treatment Sales Market Share by Country (2015-2020)
Table 48. Europe Acinetobacter Infections Treatment Revenue by Country (2015-2020) (US$ Million)
Table 49. Europe Acinetobacter Infections Treatment Revenue Market Share by Country (2015-2020)
Table 50. Europe Acinetobacter Infections Treatment Sales by Type (2015-2020) (Cases)
Table 51. Europe Acinetobacter Infections Treatment Sales Market Share by Type (2015-2020)
Table 52. Europe Acinetobacter Infections Treatment Sales by Application (2015-2020) (Cases)
Table 53. Europe Acinetobacter Infections Treatment Sales Market Share by Application (2015-2020)
Table 54. Asia Pacific Acinetobacter Infections Treatment Sales by Region (2015-2020) (Cases)
Table 55. Asia Pacific Acinetobacter Infections Treatment Sales Market Share by Region (2015-2020)
Table 56. Asia Pacific Acinetobacter Infections Treatment Revenue by Region (2015-2020) (US$ Million)
Table 57. Asia Pacific Acinetobacter Infections Treatment Revenue Market Share by Region (2015-2020)
Table 58. Asia Pacific Acinetobacter Infections Treatment Sales by Type (2015-2020) (Cases)
Table 59. Asia Pacific Acinetobacter Infections Treatment Sales Market Share by Type (2015-2020)
Table 60. Asia Pacific Acinetobacter Infections Treatment Sales by Application (2015-2020) (Cases)
Table 61. Asia Pacific Acinetobacter Infections Treatment Sales Market Share by Application (2015-2020)
Table 62. Latin America Acinetobacter Infections Treatment Sales by Country (2015-2020) (Cases)
Table 63. Latin America Acinetobacter Infections Treatment Sales Market Share by Country (2015-2020)
Table 64. Latin Americaa Acinetobacter Infections Treatment Revenue by Country (2015-2020) (US$ Million)
Table 65. Latin America Acinetobacter Infections Treatment Revenue Market Share by Country (2015-2020)
Table 66. Latin America Acinetobacter Infections Treatment Sales by Type (2015-2020) (Cases)
Table 67. Latin America Acinetobacter Infections Treatment Sales Market Share by Type (2015-2020)
Table 68. Latin America Acinetobacter Infections Treatment Sales by Application (2015-2020) (Cases)
Table 69. Latin America Acinetobacter Infections Treatment Sales Market Share by Application (2015-2020)
Table 70. Middle East and Africa Acinetobacter Infections Treatment Sales by Country (2015-2020) (Cases)
Table 71. Middle East and Africa Acinetobacter Infections Treatment Sales Market Share by Country (2015-2020)
Table 72. Middle East and Africa Acinetobacter Infections Treatment Revenue by Country (2015-2020) (US$ Million)
Table 73. Middle East and Africa Acinetobacter Infections Treatment Revenue Market Share by Country (2015-2020)
Table 74. Middle East and Africa Acinetobacter Infections Treatment Sales by Type (2015-2020) (Cases)
Table 75. Middle East and Africa Acinetobacter Infections Treatment Sales Market Share by Type (2015-2020)
Table 76. Middle East and Africa Acinetobacter Infections Treatment Sales by Application (2015-2020) (Cases)
Table 77. Middle East and Africa Acinetobacter Infections Treatment Sales Market Share by Application (2015-2020)
Table 78. Entasis Therapeutics Corporation Information
Table 79. Entasis Therapeutics Description and Major Businesses
Table 80. Entasis Therapeutics Acinetobacter Infections Treatment Production (Cases), Revenue (US$ Million), Price (USD/Case) and Gross Margin (2015-2020)
Table 81. Entasis Therapeutics Product
Table 82. Entasis Therapeutics Recent Development
Table 83. Roche Corporation Information
Table 84. Roche Description and Major Businesses
Table 85. Roche Acinetobacter Infections Treatment Production (Cases), Revenue (US$ Million), Price (USD/Case) and Gross Margin (2015-2020)
Table 86. Roche Product
Table 87. Roche Recent Development
Table 88. Adenium Biotech Corporation Information
Table 89. Adenium Biotech Description and Major Businesses
Table 90. Adenium Biotech Acinetobacter Infections Treatment Production (Cases), Revenue (US$ Million), Price (USD/Case) and Gross Margin (2015-2020)
Table 91. Adenium Biotech Product
Table 92. Adenium Biotech Recent Development
Table 93. Vaxdyn Corporation Information
Table 94. Vaxdyn Description and Major Businesses
Table 95. Vaxdyn Acinetobacter Infections Treatment Production (Cases), Revenue (US$ Million), Price (USD/Case) and Gross Margin (2015-2020)
Table 96. Vaxdyn Product
Table 97. Vaxdyn Recent Development
Table 98. Hsiri Therapeutics Corporation Information
Table 99. Hsiri Therapeutics Description and Major Businesses
Table 100. Hsiri Therapeutics Acinetobacter Infections Treatment Production (Cases), Revenue (US$ Million), Price (USD/Case) and Gross Margin (2015-2020)
Table 101. Hsiri Therapeutics Product
Table 102. Hsiri Therapeutics Recent Development
Table 103. Aridis Pharmaceuticals Corporation Information
Table 104. Aridis Pharmaceuticals Description and Major Businesses
Table 105. Aridis Pharmaceuticals Acinetobacter Infections Treatment Production (Cases), Revenue (US$ Million), Price (USD/Case) and Gross Margin (2015-2020)
Table 106. Aridis Pharmaceuticals Product
Table 107. Aridis Pharmaceuticals Recent Development
Table 108. LegoChem Biosciences Corporation Information
Table 109. LegoChem Biosciences Description and Major Businesses
Table 110. LegoChem Biosciences Acinetobacter Infections Treatment Production (Cases), Revenue (US$ Million), Price (USD/Case) and Gross Margin (2015-2020)
Table 111. LegoChem Biosciences Product
Table 112. LegoChem Biosciences Recent Development
Table 113. Atterx Biotherapeutics Corporation Information
Table 114. Atterx Biotherapeutics Description and Major Businesses
Table 115. Atterx Biotherapeutics Acinetobacter Infections Treatment Production (Cases), Revenue (US$ Million), Price (USD/Case) and Gross Margin (2015-2020)
Table 116. Atterx Biotherapeutics Product
Table 117. Atterx Biotherapeutics Recent Development
Table 118. Achaogen Corporation Information
Table 119. Achaogen Description and Major Businesses
Table 120. Achaogen Acinetobacter Infections Treatment Production (Cases), Revenue (US$ Million), Price (USD/Case) and Gross Margin (2015-2020)
Table 121. Achaogen Product
Table 122. Achaogen Recent Development
Table 123. Peptilogics Corporation Information
Table 124. Peptilogics Description and Major Businesses
Table 125. Peptilogics Acinetobacter Infections Treatment Production (Cases), Revenue (US$ Million), Price (USD/Case) and Gross Margin (2015-2020)
Table 126. Peptilogics Product
Table 127. Peptilogics Recent Development
Table 128. Sealife PHARMA Corporation Information
Table 129. Sealife PHARMA Description and Major Businesses
Table 130. Sealife PHARMA Acinetobacter Infections Treatment Sales (Cases), Revenue (US$ Million), Price (USD/Case) and Gross Margin (2015-2020)
Table 131. Sealife PHARMA Product
Table 132. Sealife PHARMA Recent Development
Table 133. Shionogi Corporation Information
Table 134. Shionogi Description and Major Businesses
Table 135. Shionogi Acinetobacter Infections Treatment Sales (Cases), Revenue (US$ Million), Price (USD/Case) and Gross Margin (2015-2020)
Table 136. Shionogi Product
Table 137. Shionogi Recent Development
Table 138. Techulon Corporation Information
Table 139. Techulon Description and Major Businesses
Table 140. Techulon Acinetobacter Infections Treatment Sales (Cases), Revenue (US$ Million), Price (USD/Case) and Gross Margin (2015-2020)
Table 141. Techulon Product
Table 142. Techulon Recent Development
Table 143. Tetraphase Pharmaceuticals Corporation Information
Table 144. Tetraphase Pharmaceuticals Description and Major Businesses
Table 145. Tetraphase Pharmaceuticals Acinetobacter Infections Treatment Sales (Cases), Revenue (US$ Million), Price (USD/Case) and Gross Margin (2015-2020)
Table 146. Tetraphase Pharmaceuticals Product
Table 147. Tetraphase Pharmaceuticals Recent Development
Table 148. Global Acinetobacter Infections Treatment Sales Forecast by Regions (2021-2026) (Cases)
Table 149. Global Acinetobacter Infections Treatment Sales Market Share Forecast by Regions (2021-2026)
Table 150. Global Acinetobacter Infections Treatment Revenue Forecast by Regions (2021-2026) (US$ Million)
Table 151. Global Acinetobacter Infections Treatment Revenue Market Share Forecast by Regions (2021-2026)
Table 152. North America: Acinetobacter Infections Treatment Sales Forecast by Country (2021-2026) (Cases)
Table 153. North America: Acinetobacter Infections Treatment Revenue Forecast by Country (2021-2026) (US$ Million)
Table 154. Europe: Acinetobacter Infections Treatment Sales Forecast by Country (2021-2026) (Cases)
Table 155. Europe: Acinetobacter Infections Treatment Revenue Forecast by Country (2021-2026) (US$ Million)
Table 156. Asia Pacific: Acinetobacter Infections Treatment Sales Forecast by Region (2021-2026) (Cases)
Table 157. Asia Pacific: Acinetobacter Infections Treatment Revenue Forecast by Region (2021-2026) (US$ Million)
Table 158. Latin America: Acinetobacter Infections Treatment Sales Forecast by Country (2021-2026) (Cases)
Table 159. Latin America: Acinetobacter Infections Treatment Revenue Forecast by Country (2021-2026) (US$ Million)
Table 160. Middle East and Africa: Acinetobacter Infections Treatment Sales Forecast by Country (2021-2026) (Cases)
Table 161. Middle East and Africa: Acinetobacter Infections Treatment Revenue Forecast by Country (2021-2026) (US$ Million)
Table 162. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 163. Key Challenges
Table 164. Market Risks
Table 165. Main Points Interviewed from Key Acinetobacter Infections Treatment Players
Table 166. Acinetobacter Infections Treatment Customers List
Table 167. Acinetobacter Infections Treatment Distributors List
Table 168. Research Programs/Design for This Report
Table 169. Key Data Information from Secondary Sources
Table 170. Key Data Information from Primary Sources
List of FiguresFigure 1. Acinetobacter Infections Treatment Product Picture
Figure 2. Global Acinetobacter Infections Treatment Sales Market Share by Type in 2020 & 2026
Figure 3. Sulbactam Product Picture
Figure 4. Carbapenems Product Picture
Figure 5. Aminoglycosides Product Picture
Figure 6. Polymyxins Product Picture
Figure 7. Tetracyclines Product Picture
Figure 8. Others Product Picture
Figure 9. Global Acinetobacter Infections Treatment Sales Market Share by Application in 2020 & 2026
Figure 10. ETX2514
Figure 11. Nacubactam RG6080
Figure 12. Arenicin
Figure 13. VXD-001
Figure 14. Small molecule antibiotic
Figure 15. AR-401 mAB
Figure 16. LCB01-0371 (PO)
Figure 17. GN-4474
Figure 18. Antibacterial Antibody
Figure 19. Acinetobacter Infections Treatment Report Years Considered
Figure 20. Global Acinetobacter Infections Treatment Market Size 2015-2026 (US$ Million)
Figure 21. Global Acinetobacter Infections Treatment Sales 2015-2026 (Cases)
Figure 22. Global Acinetobacter Infections Treatment Market Size Market Share by Region: 2020 Versus 2026
Figure 23. Global Acinetobacter Infections Treatment Sales Market Share by Region (2015-2020)
Figure 24. Global Acinetobacter Infections Treatment Sales Market Share by Region in 2019
Figure 25. Global Acinetobacter Infections Treatment Revenue Market Share by Region (2015-2020)
Figure 26. Global Acinetobacter Infections Treatment Revenue Market Share by Region in 2019
Figure 27. Global Acinetobacter Infections Treatment Sales Share by Manufacturer in 2019
Figure 28. The Top 10 and 5 Players Market Share by Acinetobacter Infections Treatment Revenue in 2019
Figure 29. Acinetobacter Infections Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 30. Global Acinetobacter Infections Treatment Sales Market Share by Type (2015-2020)
Figure 31. Global Acinetobacter Infections Treatment Sales Market Share by Type in 2019
Figure 32. Global Acinetobacter Infections Treatment Revenue Market Share by Type (2015-2020)
Figure 33. Global Acinetobacter Infections Treatment Revenue Market Share by Type in 2019
Figure 34. Global Acinetobacter Infections Treatment Market Share by Price Range (2015-2020)
Figure 35. Global Acinetobacter Infections Treatment Sales Market Share by Application (2015-2020)
Figure 36. Global Acinetobacter Infections Treatment Sales Market Share by Application in 2019
Figure 37. Global Acinetobacter Infections Treatment Revenue Market Share by Application (2015-2020)
Figure 38. Global Acinetobacter Infections Treatment Revenue Market Share by Application in 2019
Figure 39. North America Acinetobacter Infections Treatment Sales Growth Rate 2015-2020 (Cases)
Figure 40. North America Acinetobacter Infections Treatment Revenue Growth Rate 2015-2020 (US$ Million)
Figure 41. North America Acinetobacter Infections Treatment Sales Market Share by Country in 2019
Figure 42. North America Acinetobacter Infections Treatment Revenue Market Share by Country in 2019
Figure 43. U.S. Acinetobacter Infections Treatment Sales Growth Rate (2015-2020) (Cases)
Figure 44. U.S. Acinetobacter Infections Treatment Revenue Growth Rate (2015-2020) (US$ Million)
Figure 45. Canada Acinetobacter Infections Treatment Sales Growth Rate (2015-2020) (Cases)
Figure 46. Canada Acinetobacter Infections Treatment Revenue Growth Rate (2015-2020) (US$ Million)
Figure 47. North America Acinetobacter Infections Treatment Market Share by Type in 2019
Figure 48. North America Acinetobacter Infections Treatment Market Share by Application in 2019
Figure 49. Europe Acinetobacter Infections Treatment Sales Growth Rate 2015-2020 (Cases)
Figure 50. Europe Acinetobacter Infections Treatment Revenue Growth Rate 2015-2020 (US$ Million)
Figure 51. Europe Acinetobacter Infections Treatment Sales Market Share by Country in 2019
Figure 52. Europe Acinetobacter Infections Treatment Revenue Market Share b